Latest Ratings for ENTA
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | SVB Leerink | Maintains | Market Perform | |
| Jan 2022 | SVB Leerink | Maintains | Market Perform | |
| Nov 2021 | Oppenheimer | Maintains | Perform |
The Analyst Verdict: Enanta Pharma In The Eyes Of 4 Experts
Where Today's News Shapes Tomorrow
